Neuroaspis was presented at DGN Congress during Neurowoche 2018, 30/10-3/11 in Berlin. DGN Congress is one of the largest German-speaking medical congresses and one of the three most visited neurological congresses worldwide. https://www.dgn.org/rubrik-dgn/der-dgn-kongress
NEUROASPIS® was presented at ECTRIMS Berlin 2018, the 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, which was held between 10-12 October in Berlin. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis.
Aniva International will be exhibiting at ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis between 10-12 October in Berlin, Germany. We look forward to meeting you there! – Stand D11
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A Pioneer Nutraceutical Formula (PLP10) for the Treatment of Relapsing Remitting Multiple Sclerosis: A Randomized, Double Blind, Placebo Controlled Proof-of-Concept Clinical Trial. Dietetic Association & AODA Regional Conference, 2012. http://www.palupamedical.com/resources/Nutrition-page-71.pdf
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A novel oral medical nutrition formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: a randomized, double-blind, placebocontrolled proof-of-concept clinical trial. AJCN, ASN; 2nd American Society for Nutrition Middle East Congress. Dubai, 2013 https://www.nutrition.org/education-and-professional-development/archived-content-from-past-meetings-and-professional-development-events/2nd-american-society-for-nutrition-middle-east-congress/
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Pioneer oral nutraceutical formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: A randomized, double-blind, placebocontrolled proof-of-concept clinical trial. Pharma Nutrition journal-Elsevier; Singapore, 2013 http://www.pharma-nutrition.com/resources/downloads/Oral%20Program%20-%2019.03.2013.pdf
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A novel oral medical nutrition formula (PLP10) for the treatment of relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to the 3rd International Congress on Neurobiology, Psychopharmacology & Treatment Guidance (Thessaloniki Greece, 2013) http://www.psychiatry.gr/3icnpepatg/posters.pdf
Marios C. Pantzaris, George N. Loukaides, Evangelia E. Ntzani & Ioannis S. Patrikios. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial. Greek Neurological Society, Thessaloniki 2013 (link: http://www.enee.gr/en/images/conf/2013_06_20_26th_congr_ene/2013_06_20_26th_congr_ene.pdf)
Systems Medicine, a Novel Approach to Chronic Diseases: the example of PLP10 Multiple Sclerosis intervention treatment, a phase II clinical trial
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Systems Medicine, Applying Systems Biology Approaches for Multiple Sclerosis Treatment by the Use of Specific Structured Μolecules and Antioxidant Vitamins: the PLP10 Novel Ιntervention Paradigm; 6th International Conference on Drug Discovery and Therapy, Dubai 2014. http://www.icddt.com/files/6th-Abstract%20Book.pdf
